| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $81.46B | +51.4% |
| Cost of Revenue | $60.61B | +50.7% |
| Gross Profit | $20.85B | +53.3% |
| R&D Expense | $3.08B | +18.6% |
| SG&A Expense | $3.95B | -12.6% |
| Operating Income | $13.66B | +109.4% |
| Interest Expense | $191.0M | -48.5% |
| Pre-tax Income | $13.72B | +116.3% |
| Income Tax | $1.13B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.25B | -7.5% |
| Short-term Investments | $5.93B | +4428.2% |
| Accounts Receivable | $2.95B | +54.3% |
| Inventory | $12.84B | +123.0% |
| Current Assets | $40.92B | +51.0% |
| Total Assets | $82.34B | +32.5% |
| Current Liabilities | $26.71B | +35.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $14.72B | +28.1% |
| Capital Expenditures | $7.16B | +10.4% |
| Investing Cash Flow | -$11.97B | -52.2% |
| Financing Cash Flow | -$3.53B | +32.2% |
| Free Cash Flow | $7.57B | +50.9% |
| +61.9% |
| Net Income | $12.56B | +127.5% |
| EPS (Basic) | $4.02 | -28.2% |
| EPS (Diluted) | $3.62 | -26.1% |
| Long-term Debt |
| $1.03B |
| -75.8% |
| Total Liabilities | $36.44B | +19.3% |
| Stockholders' Equity | $44.70B | +48.1% |